BHVNBiohaven Ltd.

HealthcareUSD
$16.95

The financials

Biohaven Ltd. by the numbers

Biohaven Ltd. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$125M−$212Mn/a
Net income−$137M−$198Mn/a
Diluted EPS−$0.91−$1.94n/a

Biotechnology

Ranks #99 of 145 by Smart Score

Compare peers
MLYS+2.2%
Mineralys Therapeutics, Inc.
NRIX+16%
Nurix Therapeutics, Inc.
PHVS+0.03%
Pharvaris N.V.
SLBT+12%
SL Science Holding Limited
MRVI+6.2%
Maravai LifeSciences Holdings, Inc.
AUPH-5.7%
Aurinia Pharmaceuticals Inc.